title: [Genomic Instability in Acute Transformation of Chronic Myelogenous Leukemia].
abstract: Chronic myeloid leukemia (CML) is a myeloproliferative disorder, characterized by excessive proliferation of myeloid cells. CML patients in early phase [also known as chronic phase (CP)] usually respond to treatment with tyrosine kinase inhibitors (TKI), some patients respond initially to TKI, but later become resistant, then resulting in the transformation from CP to more advanced phase, which were subclassified as either accelerated phase or blastic phase. At present, the molecular mechanisms of CML have been not yet clear, and acute transformation has been not fully understood, studies have shown that genomic instability promotes the acute conversion of CML. This review discusses the molecular mechanisms leading to the transformation of CML, and some therapeutic approaches.
authors: Department of Hematology, Hengshui Harlson International Peace Hospital, Hengshui 053000, Hebei Province, China.
authors: Su-Qing
authors: SQ
authors: Guo
authors: Department of Hematology, Hengshui Harlson International Peace Hospital, Hengshui 053000, Hebei Province, China. E-mail: 1445828799@qq.com.
authors: Ying-Hua
authors: YH
authors: Li
mesh_terms: D001752:Blast Crisis; D019008:Drug Resistance, Neoplasm; D042822:Genomic Instability; D006801:Humans; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive